← Back to Search

APPRAISE cases for Wounds and Injuries

Phase 1

Recruiting

Led By Andrew Reisner, MD

Research Sponsored by Andrew Tomas Reisner

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Triaged to the 'Acute' area of the ED (designated for patients with potential or established critical illness)

Adult (≥18 yrs) Emergency Department (ED) patient

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from patient arrival in the emergency department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation)

Awards & highlights

Study Summary

This trial is testing a software system called APPRAISE that helps clinicians make decisions for trauma patients. The trial aims to see if the software works well in real-time, if it distracts or conf

Who is the study for?

This trial is for adults (18+) who arrive at the Emergency Department and are triaged to the 'Acute' area due to concerns of acute injury. This could be because they've reported an injury or the clinical team suspects one based on their symptoms.Check my eligibility

What is being tested?

The APPRAISE Trauma Clinical Decision Support System is being tested. It's a software designed to help clinicians make decisions in treating trauma patients, and this trial checks if it works as intended without distracting doctors.See study design

What are the potential side effects?

Since this trial involves a decision-support system rather than medication, traditional side effects aren't expected. However, there may be risks related to potential distraction or confusion among clinicians using the system.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was directed to the critical care section of the emergency department.

Select...

I am 18 years or older and currently in the emergency department.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from patient arrival in the emergency department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation).

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from patient arrival in the emergency department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation).

This trial's timeline: 3 weeks for screening, Varies for treatment, and from patient arrival in the emergency department through enrollment, protocol initiation, and protocol completion (which is typically 30 min after protocol initiation). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Clinician surveys that ongoing use of the software poses risks that exceeds benefits

Clinician surveys that the software negatively affected patient care

Clinician surveys that the software positively affected patient care

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: APPRAISE casesExperimental Treatment1 Intervention

Trauma patients for which APPRAISE system was used

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Andrew Tomas ReisnerLead Sponsor

1 Previous Clinical Trials

20 Total Patients Enrolled

Andrew Reisner, MDPrincipal InvestigatorMass. General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this medical study currently open?

"According to the details provided on clinicaltrials.gov, this study is actively seeking volunteers. It was first listed on February 21st, 2023 and last revised on February 21st, 2024."

Answered by AI

Are the cases evaluated by APPRAISE given the green light by the FDA?

"Given that this is a Phase 1 trial with limited safety and efficacy data, APPRAISE cases were assigned a safety rating of 1 by our team at Power."

Answered by AI

What is the total number of participants being recruited for this clinical investigation?

"Affirmative. Details on clinicaltrials.gov highlight the ongoing recruitment of participants for this particular medical trial. It was first made public on February 21, 2023, and most recently updated on February 21, 2024. The study aims to enroll a total of twenty patients from one designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System

Andrew Tomas Reisner 2023. "APPRAISE 2.0: Live Trial of the APPRAISE Trauma Decision Support System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06121661.